Suxibuzone
From Infogalactic: the planetary knowledge core
File:Suxibuzone.png | |
Systematic (IUPAC) name | |
---|---|
4-[ [4-butyl-3,5-dioxo-1,2-di(phenyl)pyrazolidin-4-yl]methoxy]-4-oxobutanoic acid
|
|
Clinical data | |
AHFS/Drugs.com | International Drug Names |
Identifiers | |
ATC code | M02AA22 (WHO) QM01AA90 (WHO) |
PubChem | CID: 5362 |
ChemSpider | 5169 ![]() |
UNII | 86TDZ5WP2B ![]() |
KEGG | D01289 ![]() |
ChEMBL | CHEMBL1414320 ![]() |
Chemical data | |
Formula | C24H26N2O6 |
Molecular mass | 438.47304 g/mol |
|
|
|
|
![]() ![]() |
Suxibuzone is a drug used for joint and muscular pain. It is a prodrug of the non steroidal anti inflammatory drug phenylbutazone, and is commonly used in horses.
<templatestyles src="Asbox/styles.css"></templatestyles>
Categories:
- Pages with broken file links
- Chemical articles having calculated molecular weight overwritten
- Articles with changed InChI identifier
- Infobox drug articles without a structure image
- Chemical articles without CAS Registry Number
- Chemical pages without DrugBank identifier
- Drugs with no legal status
- Pyrazolidindiones
- Carboxylate esters
- Musculoskeletal system drug stubs